CVRx, Inc. Revenue
CVRx, Inc. (CVRX) reported Revenue of $15.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $15.71M, a 15.57% increase year-over-year.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $14.77M, a 19.61% increase year-over-year.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $16.02M, a 4.45% increase year-over-year.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $14.69M, a 9.85% increase year-over-year.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $56.65M, a 10.45% increase from fiscal 2024.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $51.29M, a 30.53% increase from fiscal 2023.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $39.30M, a 74.89% increase from fiscal 2022.
- CVRx, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $22.47M, a 72.36% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.71M 10-Q · filed 2026-08-06 | $30.47M 10-Q · filed 2026-08-06 | $46.50M derived: sum of 3 quarters · filed 2026-08-06 | $61.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $14.77M 10-Q · filed 2026-05-12 | $30.79M derived: sum of 2 quarters · filed 2026-05-12 | $45.48M derived: sum of 3 quarters · filed 2026-05-12 | $59.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $30.71M derived: sum of 2 quarters · filed 2026-02-13 | $44.30M derived: sum of 3 quarters · filed 2026-08-06 | $56.65M 10-K · filed 2026-02-13 |
| 2025-09-30 | $14.69M 10-Q · filed 2025-11-06 | $28.28M derived: sum of 2 quarters · filed 2026-08-06 | $40.63M 10-Q · filed 2025-11-06 | $55.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $13.59M 10-Q · filed 2026-08-06 | $25.94M 10-Q · filed 2026-08-06 | $41.28M derived: sum of 3 quarters · filed 2026-08-06 | $54.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $12.35M 10-Q · filed 2026-05-12 | $27.69M derived: sum of 2 quarters · filed 2026-05-12 | $41.06M derived: sum of 3 quarters · filed 2026-05-12 | $52.87M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $15.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $28.71M derived: sum of 2 quarters · filed 2026-02-13 | $40.52M derived: sum of 3 quarters · filed 2026-02-13 | $51.29M 10-K · filed 2026-02-13 |
| 2024-09-30 | $13.37M 10-Q · filed 2025-11-06 | $25.18M derived: sum of 2 quarters · filed 2025-11-06 | $35.95M 10-Q · filed 2025-11-06 | $47.26M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $11.81M 10-Q · filed 2025-08-05 | $22.58M 10-Q · filed 2025-08-05 | $33.88M derived: sum of 3 quarters · filed 2025-08-05 | $44.39M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $10.77M 10-Q · filed 2025-05-09 | $22.07M derived: sum of 2 quarters · filed 2025-05-09 | $32.59M derived: sum of 3 quarters · filed 2025-05-09 | $42.09M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $21.82M derived: sum of 2 quarters · filed 2025-02-18 | $31.32M derived: sum of 3 quarters · filed 2025-02-18 | $39.30M 10-K · filed 2025-02-18 |
| 2023-09-30 | $10.51M 10-Q · filed 2024-11-01 | $20.01M derived: sum of 2 quarters · filed 2024-11-01 | $27.99M 10-Q · filed 2024-11-01 | $35.17M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $9.50M 10-Q · filed 2024-08-02 | $17.48M 10-Q · filed 2024-08-02 | $24.66M derived: sum of 3 quarters · filed 2024-08-02 | $30.84M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $7.98M 10-Q · filed 2024-05-10 | $15.15M derived: sum of 2 quarters · filed 2024-05-10 | $21.34M derived: sum of 3 quarters · filed 2024-05-10 | $26.37M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $13.36M derived: sum of 2 quarters · filed 2024-02-09 | $18.39M derived: sum of 3 quarters · filed 2024-02-09 | $22.47M 10-K · filed 2024-02-09 |
| 2022-09-30 | $6.19M 10-Q · filed 2023-10-31 | $11.22M derived: sum of 2 quarters · filed 2023-10-31 | $15.29M 10-Q · filed 2023-10-31 | $18.95M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $5.03M 10-Q · filed 2023-08-03 | $9.11M 10-Q · filed 2023-08-03 | $12.77M derived: sum of 3 quarters · filed 2023-08-03 | $16.16M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $4.08M 10-Q · filed 2023-05-11 | $7.73M derived: sum of 2 quarters · filed 2023-05-11 | $11.13M derived: sum of 3 quarters · filed 2023-05-11 | $14.25M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $7.05M derived: sum of 2 quarters · filed 2023-02-10 | $10.18M derived: sum of 3 quarters · filed 2023-02-10 | $13.04M 10-K · filed 2023-02-10 |
| 2021-09-30 | $3.40M 10-Q · filed 2022-11-04 | $6.52M derived: sum of 2 quarters · filed 2022-11-04 | $9.38M 10-Q · filed 2022-11-04 | $11.47M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $3.12M 10-Q · filed 2022-08-01 | $5.98M 10-Q · filed 2022-08-01 | $8.07M derived: sum of 3 quarters · filed 2022-08-01 | $9.07M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $2.86M 10-Q · filed 2022-05-02 | $4.95M derived: sum of 2 quarters · filed 2022-05-02 | $5.95M derived: sum of 3 quarters · filed 2022-05-02 | $7.20M derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $3.08M derived: sum of 2 quarters · filed 2022-02-22 | $4.33M derived: sum of 3 quarters · filed 2022-02-22 | $6.05M 10-K · filed 2022-02-22 |
| 2020-09-30 | $997.00K 10-Q · filed 2021-11-08 | $2.25M derived: sum of 2 quarters · filed 2021-11-08 | $3.96M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $1.25M 10-Q · filed 2021-08-09 | $2.97M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |